Add to ORKGThere are several treatment options available for patients who have mild persistent asthma. After being shown a typical case study and three possible treatment options, three respiratory specialists each selected a different option. The options were: using a combination beclometasone/albuterol inhaler on an as-needed basis; daily treatment with an oral leukotriene receptor antagonist together with as-needed use of a short-acting beta2-agonist (SABA) inhaler; and using a combination inhaled corticosteroid/long-acting beta2-agonist inhaler once-daily together with as-needed SABA. The evidence for each option is reviewed in the light of recent research
Asthma is a chronic respiratory disease in which airway inflammation is a key feature, even in the m...
BACKGROUND: Treatment guidelines recommend the regular use of inhaled corticosteroids for patients w...
In studies comparing regular versus on-demand treatment for patients with mild persistent asthma, on...
Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduce...
Current national and international guidelines recommend regularly scheduled treatment with inhaled c...
Mild asthma is prevalent in childhood and causes as many as 30%-40% asthma exacerbations requiring e...
Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduce...
Asthma is a chronic respiratory disease in which airway inflammation is a key feature, even in the m...
In studies comparing regular versus on demand treatment for patients with mild persistent asthma, on...
It is estimated that 50-75% of bronchial asthma cases have mild (intermittent or persistent) severit...
In the last few years much attention has been focused on research on severe asthma and the role of b...
Apart from avoiding airway-irritating agents, the most important issue in the treatment of asthma is...
Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduce...
Treatment guidelines recommend the regular use of inhaled corticosteroids for patients with mild ...
AbstractThe purpose of this study was to compare the efficacy and safety of the inhaled budesonide, ...
Asthma is a chronic respiratory disease in which airway inflammation is a key feature, even in the m...
BACKGROUND: Treatment guidelines recommend the regular use of inhaled corticosteroids for patients w...
In studies comparing regular versus on-demand treatment for patients with mild persistent asthma, on...
Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduce...
Current national and international guidelines recommend regularly scheduled treatment with inhaled c...
Mild asthma is prevalent in childhood and causes as many as 30%-40% asthma exacerbations requiring e...
Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduce...
Asthma is a chronic respiratory disease in which airway inflammation is a key feature, even in the m...
In studies comparing regular versus on demand treatment for patients with mild persistent asthma, on...
It is estimated that 50-75% of bronchial asthma cases have mild (intermittent or persistent) severit...
In the last few years much attention has been focused on research on severe asthma and the role of b...
Apart from avoiding airway-irritating agents, the most important issue in the treatment of asthma is...
Mild persistent asthma should be treated with continuous inhaled corticosteroids (ICS), which reduce...
Treatment guidelines recommend the regular use of inhaled corticosteroids for patients with mild ...
AbstractThe purpose of this study was to compare the efficacy and safety of the inhaled budesonide, ...
Asthma is a chronic respiratory disease in which airway inflammation is a key feature, even in the m...
BACKGROUND: Treatment guidelines recommend the regular use of inhaled corticosteroids for patients w...
In studies comparing regular versus on-demand treatment for patients with mild persistent asthma, on...